3
Announcements
Trials
Browse
Landscape
Status
Completed
309
Terminated
81
Recruiting
81
Active not recruiting
45
Unknown
39
Withdrawn
19
Not yet recruiting
10
Enrolling by invitation
4
No longer available
2
Suspended
1
Available
1
Approved for marketing
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
20
Thoracic
7
Gastrointestinal
7
Other solid neoplasm
3
Other hematologic neoplasm
3
Gynecologic
3
Genitourinary
3
CNS
3
Other
2
Head & Neck
2
Breast
2
Myeloid
1
Lymphoid
1
Endocrine
1
Dermatologic
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma
9
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, B-Cell
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, T-Cell
4
Lymphoma, Follicular
4
Leukemia, Myeloid, Acute
4
Immunoblastic Lymphadenopathy
4
Hematologic Neoplasms
4
Lymphoma, T-Cell, Peripheral
3
Leukemia
3
Recurrence
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Anaplastic
2
Hodgkin Disease
2
Dendritic Cell Sarcoma, Interdigitating
2
Burkitt Lymphoma
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Spondylolisthesis
1
Spinal Stenosis
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Neurotoxicity Syndromes
1
Neoplasms by Histologic Type
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Neoplasms
×
Lymphoid
×
Clear all
NCT03659669
2023-10-23
REVEAL
AbbVie
Suspended
272 enrolled